This drug might be available by summer of 2021. Much more here.

Source: Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir – Merck.com

Therapeutics drugs, vaccines, and natural population immunity might bring this to an end soon.